Handelsbanken Fonder
CYTK icon

Handelsbanken Fonder’s Cytokinetics CYTK Stock Holding History

Handelsbanken Fonder’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.5M Buy
405,000
+157,700
+64% +$11.3M 0.1% 174
2026
Q1 		$16.3M Buy
247,300
+41,500
+20% +$2.64M 0.05% 270
2025
Q4 		$13.1M Sell
205,800
-28,700
-12% -$1.79M 0.04% 346
2025
Q3 		$12.9M Buy
234,500
+202,200
+626% +$8.33M 0.04% 338
2025
Q2 		$1.07M Hold
32,300
– – ﹤0.01% 931
2025
Q1 		$1.3M Hold
32,300
– – 0.01% 834
2024
Q4 		$1.52M Buy
32,300
+2,900
+10% +$151K 0.01% 784
2024
Q3 		$1.55M Buy
29,400
+5,900
+25% +$329K 0.01% 752
2024
Q2 		$1.27M Buy
23,500
+800
+4% +$48.3K 0.01% 735
2024
Q1 		$1.59M Buy
22,700
+2,900
+15% +$224K 0.01% 671
2023
Q4 		$1.65M Buy
19,800
+2,400
+14% +$86.9K 0.01% 604
2023
Q3 		$513K Hold
17,400
– – ﹤0.01% 1041
2023
Q2 		$568K Buy
17,400
+4,800
+38% +$178K ﹤0.01% 1000
2023
Q1 		$443K Hold
12,600
– – ﹤0.01% 1059
2022
Q4 		$577K Buy
12,600
+800
+7% +$34.4K ﹤0.01% 883
2022
Q3 		$572K Hold
11,800
– – ﹤0.01% 884
2022
Q2 		$464K Hold
11,800
– – ﹤0.01% 1069
2022
Q1 		$434K Sell
11,800
-4,700
-28% -$167K ﹤0.01% 1304
2021
Q4 		$752K Hold
16,500
– – ﹤0.01% 1070
2021
Q3 		$590K Hold
16,500
– – ﹤0.01% 1243
2021
Q2 		$327K Buy
16,500
+1,100
+7% +$25.8K ﹤0.01% 1607
2021
Q1 		$358K Hold
15,400
– – ﹤0.01% 1369
2020
Q4 		$320K Buy
+15,400
New +$281K ﹤0.01% 1373

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Handelsbanken Fonder's CYTK Position: Q2 2026 in Review

Handelsbanken Fonder increased its Cytokinetics (CYTK) stake by 64% in Q2 2026, buying an estimated $11.3M and bringing the position to 405,000 shares worth $34.5M. The position accounts for 0.1% of the portfolio, ranked #174.

Handelsbanken Fonder first reported a position in CYTK in Q4 2020 and has held it in 23 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Handelsbanken Fonder held 405,000 shares of Cytokinetics worth $34.5M as of Q2 2026.
  • Handelsbanken Fonder bought 157,700 Cytokinetics shares in Q2 2026, an estimated $11.3M.
  • Cytokinetics made up 0.1% of Handelsbanken Fonder's portfolio in Q2 2026, its #174 holding.
  • Handelsbanken Fonder first reported a position in Cytokinetics in Q4 2020 and has held it in 23 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.